“GLP-1 analogues are reshaping diabetes and obesity care as innovation in drug delivery, expanding indications, and strong R&D pipelines drive explosive global demand.”Boston, Jan. 30, 2026 (GLOBE NEWSWIRE) — The GLP-1 analogue market is experiencing rapid expansion as the world faces rising obesity and diabetes prevalence, alongside strong demand for effective metabolic therapies. According to BCC Research’s Global GLP-1 Analogues Market report, the market was valued at $54.8 billion in 2024 aRead More
Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030
